Eric O'Neill

Professor of Cell and Molecular Biology

Our research aims to understand the cell and molecular biology behind frequent tumour mutations and how they influence cancer onset and/or therapy.

Academic

Clinical

Industry

Postdocs

Keaton Jones, Academic Clinical Lecturer

TBA

Post Graduates

Daniel Hughes, Clinical Research Training Fellow

Sophie Hughes, DPhil student

Haonan Xu, DPhil student

Cameron Lang, DPhil student

Jaihui Liu, MSc student

Mataka Banda, MSc student

Recent Lab Alumini

Postdoc

Fiona Bangs, Cilia biology lead - Vertex Pharmaceuticals

Maria Chatzifrangkeskou, Marie Curie Fellow - University of Nicosia, Cyprus

Simone Lanfredini, Head of pre-clincial labs - Novartis (Turin), Italy

Daniela Pankova, Lab head, Charles University Prague, Czech

Dafni Pefani, ERC starting fellow - University of Patras, Greece

Post Graduate

Maria Tognoli, Hubrect Institute, Netherlands

Michael Eyres, MRC catapult

Asmita Thapa, BenevolentAI

RASSF1A disrupts the NOTCH signaling axis via SNURF/RNF4-mediated ubiquitination of HES1.
Journal article

Papaspyropoulos A. et al, (2021), EMBO Rep
RASSF1C oncogene elicits amoeboid invasion, cancer stemness, and extracellular vesicle release via a SRC/Rho axis.
Journal article

Tognoli ML. et al, (2021), EMBO J
TET2 drives 5hmc marking of GATA6 and epigenetically defines pancreatic ductal adenocarcinoma transcriptional subtypes.
Journal article

Eyres M. et al, (2021), Gastroenterology
Ciliogenesis and Hedgehog signalling are supressed downstream of KRas during acinar-ductal metaplasia.
Journal article

Bangs FK. et al, (2020), Dis Model Mech
Assessment of CCR5/maraviroc immunotherapy in combination with PD1 and MR-guided radiotherapy for treatment of pancreatic cancer.
Conference paper

Hughes S. et al, (2020), CANCER IMMUNOLOGY RESEARCH, 8, 120 - 120

More publications